HEPAZYME
Ribozyme Pharmaceuticals Incorporated
| Research |
OneLook
Acronym Finder
|
| Serial Number | 75484647 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Attorney Name | EDWARD M JORDAN |
| Attorney Docket Number | 234/123 |
| Law Office Assigned | L20 |
| Employee Name | SMIGA, HOWARD |
Timeline
| 1998-05-13 | Application Filed |
| 2005-08-02 | Published for Opposition |
| 2005-10-25 | Location: INTENT TO USE SECTION |
| 2006-04-26 | Abandon |
| 2006-04-26 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  RIBOZYME PHARMACEUTICALS INCORPORATED |
| Address | 2950 Wilderness Place Boulder DE 80301 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Medicinal and biological product research, development and testing |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1998-12-14 | 1 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 1998-12-18 | 2 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 1999-01-15 | 3 DOCK D:Assigned to Examiner |
| LETTER OF SUSPENSION MAILED | 1999-01-19 | 4 CNSL F:First Action |
| ASSIGNED TO EXAMINER | 2001-04-07 | 5 DOCK D:Assigned to Examiner |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2001-11-21 | 6 CRFA I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2002-01-22 | 7 DOCK D:Assigned to Examiner |
| LETTER OF SUSPENSION MAILED | 2002-01-24 | 8 CNSL S: |
| ASSIGNED TO EXAMINER | 2002-07-23 | 9 DOCK D:Assigned to Examiner |
| CASE FILE IN TICRS | 2004-03-18 | 10 CFIT O:Outgoing Correspondence |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2004-12-06 | 11 RCCK S: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-01-31 | 12 CNSA P: |
| ASSIGNED TO LIE | 2005-02-04 | 13 ALIE A:Allowance for Publication |
| ASSIGNED TO LIE | 2005-02-16 | 14 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-02-16 | 15 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2005-07-13 | 16 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2005-08-02 | 17 PUBO A:Allowance for Publication |
| PAPER RECEIVED | 2005-08-02 | 18 MAIL I:Incoming Correspondence |
| UNDELIVERABLE MAIL - NO ACTION TAKEN | 2005-08-02 | 19 UNDN O:Outgoing Correspondence |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2005-10-25 | 20 NOAM O:Outgoing Correspondence |
| PAPER RECEIVED | 2005-11-22 | 21 MAIL I:Incoming Correspondence |
| UNDELIVERABLE MAIL - NO ACTION TAKEN | 2005-12-02 | 22 UNDN O:Outgoing Correspondence |
| ABANDONMENT - NO USE STATEMENT FILED | 2006-06-26 | 23 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2006-06-26 | 24 MAB6 O:Outgoing Correspondence |
| UNDELIVERABLE MAIL - NO ACTION TAKEN | 2006-07-13 | 25 UNDN O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 HEPAZYME 75484647 not registered Dead/Abandoned |
RIBOZYME PHARMACEUTICALS INCORPORATED 1998-05-13 |
 HEPAZYME 75484258 not registered Dead/Abandoned |
RIBOZYME PHARMACEUTICALS INCORPORATED 1998-05-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 